Voluntary disclosures of payments from pharmaceutical companies to healthcare professionals in Germany: a descriptive study of disclosures in 2015 and 2016
Objective To analyse voluntary payment reports of pharmaceutical companies to German healthcare professionals (HCPs) in 2015 and 2016 based on an industry-self-regulating transparency codex.Design and participants Cohort study of all German HCPs who voluntarily agreed that at least one payment they...
Saved in:
Main Authors: | Marlene Stoll, Lara Hubenschmid, Cora Koch, Klaus Lieb |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-09-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/9/e037395.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Physicians’ attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey
by: Marlene Stoll, et al.
Published: (2022-06-01) -
Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012–2016)
by: Piotr Ozieranski, et al.
Published: (2020-09-01) -
Contingency perspective: company characteristics, risk management voluntary disclosure, and company performance
by: Yuliusman Yuliusman, et al.
Published: (2023-09-01) -
Voluntary Disclosures and their Drivers: A Study of MDA Reports in India
by: Himani Singla, et al.
Published: (2024-05-01) -
Voluntary Disclosure and Relational Connectivity – The Case of the Polish Bond Market
by: Dominika Hadro, et al.
Published: (2023-11-01)